NAXWAB Trademark

Trademark Overview

On Friday, March 18, 2022, a trademark application was filed for NAXWAB with the United States Patent and Trademark Office. The USPTO has given the NAXWAB trademark a serial number of 97319633. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 30, 2025. This trademark is owned by Pocket Naloxone Corp.. The NAXWAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the rapid treatment of opioid toxicity and overdosage
naxwab

General Information

Serial Number97319633
Word MarkNAXWAB
Filing DateFriday, March 18, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the rapid treatment of opioid toxicity and overdosage

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePocket Naloxone Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816
Party NamePocket Naloxone Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022NEW APPLICATION ENTERED
Tuesday, August 30, 2022ASSIGNED TO EXAMINER
Wednesday, March 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 31, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 2 FILED
Tuesday, October 10, 2023SOU EXTENSION 2 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 26, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 26, 2023SOU EXTENSION 1 FILED
Friday, May 26, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024SOU EXTENSION 3 GRANTED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2024SOU EXTENSION 3 FILED
Sunday, November 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 25, 2024SOU EXTENSION 4 GRANTED
Wednesday, May 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2024SOU EXTENSION 4 FILED
Monday, June 30, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, June 30, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

naxwab toxicity overdosage opioid treatment preparations rapid pharmaceutical